T. Rowe Price Associates’s Curis CRIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-369
Closed -$123K 2898
2023
Q2
$123K Hold
369
﹤0.01% 2654
2023
Q1
$88K Hold
369
﹤0.01% 2710
2022
Q4
$81K Hold
369
﹤0.01% 2752
2022
Q3
$104K Buy
369
+53
+17% +$21.4K ﹤0.01% 2714
2022
Q2
$125K Buy
316
+183
+138% +$76.3K ﹤0.01% 2715
2022
Q1
$127K Buy
133
+23
+21% +$29.4K ﹤0.01% 2807
2021
Q4
$209K Sell
110
-17
-13% -$40.4K ﹤0.01% 2738
2021
Q3
$398K Sell
127
-8
-6% -$25K ﹤0.01% 2468
2021
Q2
$435K Buy
135
+101
+297% +$456K ﹤0.01% 2446
2021
Q1
$152K Sell
34
-5
-13% -$20.9K ﹤0.01% 2738
2020
Q4
$129K Buy
+39
New +$46.8K ﹤0.01% 2609

Other funds holding CRIS

T. Rowe Price Associates's CRIS Position: Q3 2023 in Review

T. Rowe Price Associates sold out of Curis (CRIS) in Q3 2023, closing a stake of 369 shares — an estimated $123K sold.

T. Rowe Price Associates first reported a position in CRIS in Q4 2020 and held it in 11 quarters. The position peaked at $435K in Q2 2021. 31 funds tracked by Wall St. Rank hold CRIS as of Q3 2023.

  • T. Rowe Price Associates reported no remaining Curis position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 369 Curis shares in Q3 2023, an estimated $123K.
  • T. Rowe Price Associates first reported a position in Curis in Q4 2020 and held it in 11 quarters.
  • T. Rowe Price Associates's Curis position peaked at $435K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Curis as of Q3 2023.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.